Published in Drugs on July 30, 2011
Genome-guided discovery of diverse natural products from Burkholderia sp. J Ind Microbiol Biotechnol (2013) 0.80
NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect. Oncotarget (2015) 0.79
Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs (2010) 0.92
Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia. Am J Cardiovasc Drugs (2009) 0.86
Abiraterone acetate: in metastatic castration-resistant prostate cancer. Drugs (2011) 0.84
Histamine dihydrochloride: in the management of acute myeloid leukaemia. Drugs (2011) 0.80
Spotlight on histamine dihydrochloride in acute myeloid leukaemia. Drugs Aging (2011) 0.76
Saxagliptin: a review of its use as combination therapy in the management of type 2 diabetes mellitus in the EU. Drugs (2012) 0.76
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. Am J Clin Dermatol (2010) 0.76
Romidepsin in the treatment of T-cell lymphoma: profile report. BioDrugs (2011) 0.75
Oral colchicine (colcrys®) in the treatment and prophylaxis of gout†: profile report. Drugs Aging (2010) 0.75